Scribeable vs Twofold:
Twofold publishes real prices, includes unlimited notes, and costs less than Scribeable Pro. Credit where due. The question is whether you need documentation alone or a note that also carries risk adjustment, quality measures, calculators, orders, and rounding.
120+ clinicians · 2,600+ notes generated — real counters, no composites (scribeable.ai/transparency)
Why Physicians Switch from Twofold
HCC or risk-adjustment coding is not stated on trytwofold.com as of Jul 2026
MIPS quality measures and code-scored clinical calculators are not stated on trytwofold.com as of Jul 2026
Multi-patient rounding is not stated on trytwofold.com as of Jul 2026
Twofold Wins on Published Note Volume
Twofold publishes its price and includes unlimited notes. Its $49/month annual rate and $69/month monthly rate are both lower than Scribeable Pro. It also advertises HIPAA compliance with a BAA on every plan and HITRUST CSF. Scribeable Pro costs $79/month and includes 150 notes, so a clinician who only wants high-volume note drafting may prefer Twofold.
Coding Has Layers
Twofold advertises inline ICD-10 and CPT suggestions. Scribeable Pro also includes ICD-10 and E&M support, then adds an HCC V28 crosswalk (8,400+ entries) and MIPS measures scored in the note. HCC risk adjustment and MIPS measures are not stated on Twofold's public site as of Jul 2026.
Past the Draft
Scribeable runs a separate verification pass that asks a clarification question instead of filling a gap. It also includes 236 code-scored calculators, an orders review queue, and Rounding Mode. These calculators and multi-patient rounding are not stated on Twofold's public site as of Jul 2026.
Same Patient. Same Encounter.
See why physicians say Scribeable notes are “actually usable” — with integrated risk scores, billing codes, and clinical reasoning that typical AI scribes simply don’t generate.
HPI
62 y/o male presents with chest pain for 2 hours. Substernal, pressure-like, radiating to left arm. Associated with diaphoresis and shortness of breath. Pain started while climbing stairs. Patient has history of HTN, DM2, and hyperlipidemia. Takes lisinopril, metformin, and atorvastatin. Denies recent illness or trauma.
Assessment & Plan
*Note examples are illustrative representations based on common AI documentation patterns. “Typical AI Scribe” represents composite characteristics of standard tools and does not depict any specific product. Patient scenarios are entirely fictional. Clinical notes should always be reviewed by a licensed provider.
AI Medical Scribe Note Quality Comparison
Scribeable produces clinically enriched notes with integrated risk calculators (HEART Score, CHA₂DS₂-VASc, Wells PE, PHQ-9, Caprini VTE), automated billing code optimization (E&M levels, HCC/RAF capture, CPT codes), dangerous diagnosis exclusion documentation, evidence-based prescribing citations, CMS compliance for operative reports, HEDIS care gap tracking, and MIPS quality measure documentation. Typical AI scribes produce basic notes without these advanced clinical features.
ED Chest Pain: 62-year-old male presenting with substernal chest pressure, diaphoresis, and exertional dyspnea
HPI: 62 y/o male presents with 2 hours of substernal chest pressure, rated 8/10, radiating to left arm and jaw. Onset during exertion (climbing stairs). Associated with diaphoresis and exertional dyspnea. Pressure-like quality, unrelieved by rest. No pleuritic component, no positional variation, no reproducibility with palpation. Risk factors: HTN (10 years), DM2 (8 years), hyperlipidemia, 30-pack-year smoking history (quit 5 years ago), family history of MI (father at age 58). Current medications: lisinopril 20mg daily, metformin 1000mg BID, atorvastatin 40mg daily. Denies cocaine use, recent immobilization, or prior VTE.
Assessment & Plan: 1. Acute Chest Pain — High-risk presentation HEART Score: 7 (High Risk) - History: moderately suspicious (2), EKG: non-specific ST changes (1), Age: >65 (2), Risk factors: ≥3 (2), Troponin: pending initial (0) - Risk stratification: >12% 6-week MACE event rate → full ACS workup - Serial troponins q3h, 12-lead EKG (initial + repeat at 60 min) - ASA 325mg PO administered, heparin drip per ACS protocol - Cardiology consulted for probable cath lab activation Dangerous Diagnosis Exclusion: - STEMI: No ST elevation on initial EKG — serial monitoring - Aortic dissection: No tearing quality, no pulse differential, no mediastinal widening on CXR - PE: Low pretest probability (Wells PE: 1.5) — no immobilization, no prior VTE, no hemoptysis 2. Hypertension — BP 168/94 on arrival, improved to 142/88 post-NTG - Continue home lisinopril, recheck prior to disposition 3. DM2 — Glucose 186 on arrival - Hold metformin (contrast exposure risk), sliding scale insulin PRN
Cardiology Consult: 71-year-old female with new-onset atrial fibrillation and decompensated heart failure
HPI: 71 y/o female with known HFrEF (EF 35% on TTE 6 months ago), HTN, DM2, and CKD Stage 3a (baseline Cr 1.4), consulted for new-onset atrial fibrillation with RVR. Progressive exertional dyspnea (NYHA II → IV over 2 weeks), 3-pillow orthopnea (new), PND, and 4+ pitting edema to knees bilaterally. Weight gain of 8 lbs over 2 weeks. Triggers explored: dietary indiscretion (holiday meals), medication non-adherence (ran out of furosemide 10 days ago). No prior AF history, no palpitations previously. Denies chest pain, syncope, or presyncope.
Assessment & Plan: Reason for Consult: New-onset atrial fibrillation with RVR in setting of acute decompensated HFrEF. Requesting Service: Internal Medicine (Dr. Patel) 1. New-onset Atrial Fibrillation with RVR CHA₂DS₂-VASc Score: 5 (Female sex, age ≥75, HTN, DM, HF) - Stroke risk: 6.7%/year → strong anticoagulation indication - Rate control: avoid diltiazem (negative inotropy in HFrEF) → amiodarone 150mg IV bolus then 1mg/min × 6h - Anticoagulation: apixaban 5mg BID (preferred over warfarin given age + fall risk) - TEE prior to any cardioversion attempt if AF duration uncertain - HAS-BLED: 2 (HTN, age) — acceptable bleeding risk 2. Acute Decompensated Heart Failure (ADHF) NYHA Functional Class: IV (dyspnea at rest) - IV furosemide 80mg BID (2.5× home oral dose), net negative 1-1.5L/day - Carvedilol held (acute decompensation), restart when euvolemic - Add sacubitril/valsartan when stable (PARADIGM-HF indication: EF ≤40% on ACEi) - BNP trend: 1,840 → monitor for response to diuresis 3. CKD Stage 3a — Cr 1.4 (baseline), monitor with aggressive diuresis - KDIGO risk: moderate — monitor Cr/K daily with diuresis
Operative Note: Right total knee arthroplasty in 68-year-old male with severe tricompartmental osteoarthritis
Operative Note: Preoperative Diagnosis: Right knee severe tricompartmental osteoarthritis (Kellgren-Lawrence Grade IV) Postoperative Diagnosis: Same Procedure: Right total knee arthroplasty Surgeon: Dr. James Morrison (attending — present and scrubbed for entire case) Assistant: Dr. Chen (PGY-4) Anesthesia: Spinal with sedation (Dr. Rivera) Implants: Smith & Nephew Legion CR, Size 5 femoral / Size 4 tibial / 10mm poly insert EBL: 150 mL Tourniquet Time: 62 minutes (pneumatic, 275 mmHg) Specimens: Femoral and tibial bone cuts — to pathology Complications: None Findings: Severe tricompartmental degenerative changes with exposed subchondral bone medially, grade III chondromalacia laterally, intact PCL
Post-Operative Plan: 1. Weight Bearing: WBAT right LE with front-wheeled walker 2. DVT Prophylaxis: Enoxaparin 40mg SQ daily × 14 days + mechanical (SCDs while inpatient) 3. Pain: Multimodal — scheduled acetaminophen 1g Q6h, meloxicam 15mg daily, tramadol 50mg Q6h PRN (max 14 days) 4. Antibiotics: Ancef 2g IV × 24h post-op 5. PT: Initiate POD0 PM — CPM machine, active/passive ROM, gait training 6. Follow-up: 2 weeks (staple removal + wound check), 6 weeks (X-ray + ROM assessment) 7. VTE Risk: Caprini Score 7 (High Risk) — extended pharmacologic prophylaxis indicated
Primary Care: 55-year-old female Medicare Advantage patient with DM2, HTN, depression, and overdue preventive care
HPI: 55 y/o female Medicare Advantage patient presenting for chronic disease management follow-up. Last visit 3 months ago. Diabetes (DM2, 8 years): A1c 8.2% (up from 7.6%), reports adherence but dietary indiscretion during holidays. Home glucose logs show fasting 140-180 range. No hypoglycemic episodes. Denies polyuria, polydipsia, vision changes, or foot numbness. Last diabetic eye exam: 14 months ago (overdue). Last podiatry visit: never. Hypertension (12 years): Home BP readings averaging 135-145/85-90. Taking lisinopril 20mg daily consistently. Depression (MDD, recurrent): PHQ-9 score today: 14 (moderately severe). Persistent low mood, anhedonia, poor sleep (initial insomnia), decreased concentration. On sertraline 50mg × 6 months with partial response. Denies SI/HI, denies alcohol or substance use. Columbia Suicide Severity: negative for ideation and behavior.
Assessment & Plan: 1. DM2, Uncontrolled (A1c 8.2%) — HCC 19 - Add empagliflozin 10mg daily (SGLT2i — CV and renal benefit, EMPA-REG OUTCOME indication) - Continue metformin 500mg BID (not escalating given GI intolerance history) - Diabetic eye exam referral (overdue 2 months — HEDIS measure) - Podiatry referral for initial foot exam - Recheck A1c in 3 months, target <7% 2. Hypertension, Suboptimally Controlled — HCC (when with CKD/DM) - BP today 138/86 — above target of <130/80 (ACC/AHA for DM patients) - Increase lisinopril to 40mg daily - Home BP log review in 4 weeks 3. Major Depressive Disorder, Recurrent, Moderate — HCC 59 - PHQ-9: 14 (moderately severe) — partial response to sertraline 50mg - Increase sertraline to 100mg daily - Safety plan reviewed, crisis line provided (988) - Follow-up in 4 weeks, recheck PHQ-9 - If inadequate response → consider augmentation or psychiatry referral 4. Preventive Care Gaps Addressed: - Mammogram ordered (last: 26 months ago — HEDIS BCS measure) - Colonoscopy referral (age 55, average risk, never screened — HEDIS COL) - Tobacco screening: former smoker, quit 3 years — MIPS measure 226 - Annual flu vaccine administered today — MIPS measure 110
Feature-by-Feature Comparison
Pricing & Access
| Feature | Scribeable | Twofold |
|---|---|---|
| Published, self-serve pricingTwofold is $49/month billed annually or $69/month billed monthly. Scribeable publishes Lite at $39/month and Pro at $79/month. | ||
| Unlimited notes on the paid planTwofold includes unlimited notes. Scribeable Pro includes 150 notes per month. | ||
| Free trial with no cardTwofold advertises a 7-day free trial with no card. Scribeable offers 14 days or 15 notes, whichever comes first, with full Pro features and no card. |
Coding & Clinical Intelligence
| Feature | Scribeable | Twofold |
|---|---|---|
| ICD-10 coding suggestionsTwofold advertises inline ICD-10 and CPT auto-coding suggestions. Scribeable Pro includes ICD-10 and E&M support. | ||
| HCC V28 risk-adjustment codingNot stated on trytwofold.com as of Jul 2026 | ||
| MIPS quality measures scored in the noteNot stated on trytwofold.com as of Jul 2026 | ||
| Clinical calculators (236, code-scored)Not stated on trytwofold.com as of Jul 2026 |
Beyond the Note
| Feature | Scribeable | Twofold |
|---|---|---|
| Referral letters and other documentsTwofold advertises referral letters among its templates and describes support for every document you need. Scribeable Pro includes 35+ document types. | ||
| Multi-patient Rounding ModeNot stated on trytwofold.com as of Jul 2026 |
Competitor facts on this page are sourced to each company's own public site and verified as of 2026-07-17; see page source for the full citation list. Competitor capabilities and pricing may change after that date.
Pricing Comparison
Twofold
$49/month annually or $69/month monthly, unlimited notes
Contact for pricing
Twofold's published paid rates are lower than Scribeable Pro and include unlimited notes. Scribeable Pro is $79/month for 150 notes and adds HCC V28, MIPS measures, 236 calculators, an orders queue, and Rounding Mode.
Other AI scribes optimize for time to first draft. Scribeable optimizes for time to signed note, with a verification pass built in before you sign.
5.0 on the App Store120+
Clinicians on board
2,600+
Patient notes generated
Which Should You Choose?
Choose Twofold if you...
- Clinicians who want unlimited notes at a lower published paid price
- Clinicians who want advertised ICD-10 and CPT suggestions inline
- Clinicians who value an advertised BAA on every plan and HITRUST CSF
Frequently Asked Questions
Compare Other Alternatives
vs Dragon Copilot
Considering Microsoft Dragon Copilot, the product formerly sold as Nuance DAX? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and who each company answers to.
vs Nabla
Considering Nabla? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and the capital structure behind the "we don't train on your data" promise both companies make.
vs Abridge
Considering Abridge? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and the capital structure behind the platform.
Start Your 14-Day Free Trial — No Credit Card
Compare Scribeable to Twofold on your own terms. Generate your first note in under 5 minutes.
Scribeable vs Twofold - AI Medical Scribe Comparison
Twofold publishes real prices, includes unlimited notes, and costs less than Scribeable Pro. Credit where due. The question is whether you need documentation alone or a note that also carries risk adjustment, quality measures, calculators, orders, and rounding.
Why Physicians Switch from Twofold
- HCC or risk-adjustment coding is not stated on trytwofold.com as of Jul 2026
- MIPS quality measures and code-scored clinical calculators are not stated on trytwofold.com as of Jul 2026
- Multi-patient rounding is not stated on trytwofold.com as of Jul 2026
Why Choose Scribeable Over Twofold
- HCC V28 crosswalk (8,400+ entries) and MIPS quality measures scored in the note
- 236 clinical calculators, code-scored and validated, inside every note
- A two-stage AI pipeline with a separate verification pass that asks a clarification question instead of guessing
- Orders queue that pulls discussed orders into a review step before anything is placed
- Rounding Mode that separates one continuous recording into a note for each patient
- Bootstrapped with $0 in outside capital, with no VC, PE, or corporate parent
Twofold Wins on Published Note Volume
Twofold publishes its price and includes unlimited notes. Its $49/month annual rate and $69/month monthly rate are both lower than Scribeable Pro. It also advertises HIPAA compliance with a BAA on every plan and HITRUST CSF. Scribeable Pro costs $79/month and includes 150 notes, so a clinician who only wants high-volume note drafting may prefer Twofold.
Coding Has Layers
Twofold advertises inline ICD-10 and CPT suggestions. Scribeable Pro also includes ICD-10 and E&M support, then adds an HCC V28 crosswalk (8,400+ entries) and MIPS measures scored in the note. HCC risk adjustment and MIPS measures are not stated on Twofold's public site as of Jul 2026.
Past the Draft
Scribeable runs a separate verification pass that asks a clarification question instead of filling a gap. It also includes 236 code-scored calculators, an orders review queue, and Rounding Mode. These calculators and multi-patient rounding are not stated on Twofold's public site as of Jul 2026.
Feature Comparison: Scribeable vs Twofold
Pricing & Access
| Feature | Scribeable | Twofold |
|---|---|---|
| Published, self-serve pricing | Yes | Yes |
| Unlimited notes on the paid plan | No | Yes |
| Free trial with no card | Yes | Yes |
Coding & Clinical Intelligence
| Feature | Scribeable | Twofold |
|---|---|---|
| ICD-10 coding suggestions | Yes | Yes |
| HCC V28 risk-adjustment coding | Yes | Partial |
| MIPS quality measures scored in the note | Yes | Partial |
| Clinical calculators (236, code-scored) | Yes | Partial |
Beyond the Note
| Feature | Scribeable | Twofold |
|---|---|---|
| Referral letters and other documents | Yes | Yes |
| Multi-patient Rounding Mode | Yes | Partial |
Pricing Comparison
Scribeable: Free tier, then $39-79/month, published
Twofold: $49/month annually or $69/month monthly, unlimited notes
Twofold's published paid rates are lower than Scribeable Pro and include unlimited notes. Scribeable Pro is $79/month for 150 notes and adds HCC V28, MIPS measures, 236 calculators, an orders queue, and Rounding Mode.
Which Should You Choose?
If you want unlimited note volume for documentation alone, Twofold's published rates are lower than Scribeable Pro. If the note has to carry risk adjustment, quality measures, calculators, orders, and rounding, that is the layer Scribeable is built around.
Frequently Asked Questions
Is Twofold cheaper than Scribeable Pro?
Yes. Twofold publishes $49/month billed annually or $69/month billed monthly, with unlimited notes. Scribeable Pro is $79/month for 150 notes. Scribeable also offers Lite at $39/month and a free tier with 5 notes each month.
Does Twofold offer coding suggestions?
Yes. Twofold advertises inline ICD-10 and CPT auto-coding suggestions. HCC risk adjustment and MIPS quality measures are not stated on trytwofold.com as of Jul 2026. Scribeable Pro includes ICD-10, HCC V28, E&M support, and MIPS measures.
Does Twofold offer unlimited notes?
Yes. Twofold advertises unlimited notes. Scribeable Pro is not unlimited and includes 150 notes per month.
What does Scribeable include beyond the note?
Scribeable Pro includes 236 code-scored calculators, an orders review queue, 35+ document types, and Rounding Mode. Twofold advertises referral letters and a broad set of document templates. Its public site does not state clinical calculators or multi-patient rounding as of Jul 2026.
Sources
Twofold pricing: $49/mo billed annually or $69/mo billed monthly, with unlimited notes.
Twofold advertises inline ICD-10 and CPT auto-coding suggestions, referral-letter templates, HIPAA compliance with a BAA on every plan, HITRUST CSF, and a 7-day free trial with no card.
Scribeable pricing: Lite $39/mo, Pro $79/mo.
Explore More
Discover how Scribeable can help your practice with AI-powered clinical documentation